Background and Aim
Introduction
In patients with end-stage liver disease that is considered to be an indication for living donor liver transplantation (LDLT), immune dysfunction may be present due to long-term malnutrition or pancytopenia due to hyper-splenism. 1 LDLT recipients must also take immunosuppressants to prevent acute rejection even though infection is a major cause of death during the acute postoperative period. 2, 3 In most institutions, the immunosuppressant dosage is determined based on therapeutic drug monitoring (TDM).
However, TDM does not always reflect the effects of immunosuppression due to the lack of an objective immune function evaluation. To improve the management of LDLT recipients, a better parameter is required. Kowalski et al. reported the utility of the ImmuKnow (IK) assay (Cylex Inc., Columbia, MD, USA) for postoperative management following organ transplantation. 4 The IK assay uses phytohemagglutinin (PHA) to stimulate lymphocyte activation.
Most immune cell functions depend on a cellular energy supply; thus, the assay is designed to measure the increase in intracellular adenosine triphosphate following Kobayashi et al. 6 mitogen activation or antigenic or allogenic stimulation. The IK values were not related to the TDM of calcineurin-inhibitor drug.
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The efficacy of IK values has been reported for the late phase following liver transplantation. [7] [8] [9] [10] However, it still remains unclear how IK values change after LDLT. Furthermore, the efficacy of the IK assay during perioperative periods for LDLT recipients remains insufficient. In this study, we examined perioperative IK values in LDLT recipients and evaluated the relationship between IK values and clinical outcomes, which were primarily the occurrence of bacterial and fungal infections.
Patients and Methods

Study design
Between May 2010 and May 2013, 65 adult patients underwent LDLT at Nagasaki University Hospital. Blood samples for the IK assay were obtained from 43 of these patients prior to LDLT. The IK assay was also conducted in 21 healthy volunteers, who served as the control group (Figure 1) . The IK values of the LDLT recipients 7 were chronologically measured at postoperative weeks 1, 2, 3, and 4. The IK values were also evaluated during infectious events.
This study protocol was approved by the institutional review board of Nagasaki University Hospital, and informed consent was obtained from each recipient and healthy volunteer.
Demographics of the living donor liver transplant recipients
The 43 LDLT recipients consisted of 25 males and 18 females with a mean age of 57.6 ± 7.6 years. The indications for LDLT were as follows: type C cirrhosis in 26 patients; type B cirrhosis in 5 patients; non-B, non-C cirrhosis in 4 patients; primary biliary cirrhosis in 4 patients; Wilson's disease in 1 patient; alcoholic cirrhosis in 1 patient; acute liver failure in 1 patient; and multiple liver metastases of a rectal carcinoid in 1 patient. The patient demographics are summarized in Table 1 . Splenectomy was performed in 33 patients with severe thrombocytopenia (platelet counts < 50,000/µl) or type C liver cirrhosis prior to postoperative interferon therapy. Splenectomy had been performed in 3 patients prior to LDLT.
Kobayashi et al.
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Immunosuppressive protocols
As a basic perioperative immunosuppressive protocol, bi-therapy with tacrolimus and steroids was administered to most patients. A steroid bolus was administered intraoperatively. Tacrolimus was initiated on postoperative day (POD) 1 while tapering the steroid dosage. The target trough level of the orally administered tacrolimus was between 10 and 15 ng/mL within the first month following LDLT and 5-10 ng/mL thereafter. The corticosteroid was gradually decreased within the first three to four months. The immunosuppressant doses were adjusted after considering the clinical course and blood tacrolimus trough levels, regardless of the IK values. For patients with severe renal dysfunction, an interleukin-2 receptor inhibitor (basiliximab) was also administered on days 1 and 4 without a calcineurin inhibitor. Adjunctive mycophenolate mofetil (MMF) was also administered. When triple therapy consisting of tacrolimus, MMF, and steroids was administered, the target trough level of tacrolimus was adjusted to 5-10 ng/mL.
Postoperative bacterial and fungal infections
Post-transplant bacterial and fungal infections were defined as cases that required an additional antibacterial or antifungal agent due to a positive culture after the discontinuation of antibacterial prophylaxis. Severe infections were defined as cases requiring mechanical ventilation or surgical drainage with septic shock.
IK measurement
The perioperative immune status was evaluated using the IK assay. The
ImmuKnow assay protocol has been described in detail elsewhere. 2, 4 Briefly, 250 μL of whole blood with 750 μL of sample diluent was dispensed in 100-μL aliquots to 4 wells of a 96-well microtiter plate and was incubated for 15-18 hr with PHA in a 37°C, 5% CO2 incubator. The CD4+ T-cells were positively selected within the microwells using magnetic particles coated with anti-human CD4 monoclonal antibodies 
Evaluating the recovery of post-transplant IK values related to infections
We evaluated the relationship between the chronological changes in post-transplant IK values and infections during the month following LDLT. According to a previous report by Kowalski et al., the immune cell response can be stratified as strong (≥ 525 ng/mL), moderate (226-524 ng/mL), or low (≤ 225 ng/mL). 4 Consequently, the 225 ng/mL IK value was defined as the cut-off value in the immunosuppressive group.
The patients were divided into 2 groups according to the IK value at 2-4 weeks after 
Statistical analyses
The ages, Child-Pugh scores, the end-stage liver disease (MELD) scores, operation 
RESULTS
Comparison of the preoperative IK values
The median preoperative IK value of the 43 LDLT recipients was 48 ng/mL (range, 4-598), which was significantly lower than that of the 21 healthy volunteers (415 ng/mL) (range, 311-438) (P = 0.01) (Figure 1 ). The IK values of the male LDLT recipients prior to LDLT (79 ng/ml; range, 27-115 ng/ml) were significantly higher than those of the females (31.5 ng/ml; range, 15-54.5 ng/ml) (P = 0.01). There were no Kobayashi et al.
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significant relationships between IK values and age, DM, Child-Pugh score, or MELD score.
Post-transplant trends in the IK values
The IK value was 86.9 ± 113.9 ng/mL before LT and 204.7 ± 169.1 ng/mL at 1 week, 303.9.7 ± 192.2 ng/mL at 2 weeks, 302.8 ± 180.5 ng/mL at 3 weeks, and 309. The rate of bacterial and fungal infections in the low IK group (91.67%) was significantly higher than that in the remaining group (45%) (P < 0.001) ( Figure 3C ). values, the occurrence of severe infections was significantly increased in the group of patients with IK values less than 150 ng/mL (P < 0.001) ( Figure 4B ). The rate of bacterial and fungal infections in the very low IK group (56.3%) was significantly higher than that in the remaining group (3.6%) (P < 0.001) ( Figure 4C ).
Representative cases from the very low IK group and the remaining group are presented in Figure 5 .
The IK values significantly differed between the three groups (patients without infections (n = 13), patients with infections (n = 20), and patients with severe infections (n = 10) at 2 to 4 weeks after LDLT) ( Figure 6 ).
Other than bacterial infections, cytomegalovirus infection (CMV) was recognized in 9 patients. Furthermore, biopsy-proven acute cellular rejection (ACR) was detected in 3 patients. However, the IK values were not significantly different between patients with CMV infections or ACR and patients without these events. weeks following whole liver transplantation. 19 The immune function of the recipients was not sufficiently restored at 2 weeks following LDLT; however, the immune function in patients who undergo whole liver transplantation may be restored within this period. Thus, assessments of immune function after LDLT would be required for at least 4 weeks. A representative case is presented in Figure 5A .
Our study also demonstrated that IK value monitoring can be performed to 
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In the aforementioned case (presented in Figure 5B ), the post-LDLT patient developed postoperative pneumonia prior to the recovery of liver function, and the IK values remained low for 3 weeks. However, she recovered from the pneumonia, and the liver function and IK values also recovered.
It may be difficult to define a quantitative cut-off value to diagnose infection or rejection due to large inter-and intra-individual variations in the IK values, even among healthy individuals. Biopsy-proven acute rejection within one month following surgery was recognized in only three cases. As in previous reports, a high IK value was identified in the patient with ACR during the long-term observation period following liver transplantation. 8, 10, [23] [24] [25] This study evaluated a small number of patients, and further investigations are needed.
The limitation of this study is that it is difficult to intervene in the IK values are the means ± standard error.
IK, ImmuKnow; Pre, preoperative state; w, week. **; P < 0.05 *; P < 0.01 
